TABLE 4.
Pathogen combinations identified among patients with SARS-CoV-2 by the FTD-33 assay or respiratory culturea
| Pathogen | No. of patients coinfected by: |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HRV | IBV | HCoV NL-63 | HCoV OC43 | S. aureus | H. influenzae type b | S. pneumoniae | P. jirovecii | L. pneumophila | K. pneumoniae | M. catarrhalis | H. influenzae | A. baumannii | M. tuberculosis | |
| Human rhinovirus (n = 4) | NA | 1 | 1 | |||||||||||
| Influenza B virus (n = 2) | NA | 1 | 1 | 1 | ||||||||||
| Human coronavirus NL63 (n = 2) | NA | 1 | ||||||||||||
| Human coronavirus OC43 (n = 2) | NA | 1 | ||||||||||||
| S. aureus (n = 25) | 1 | 1 | NA | 2 | 3 | 1 | 7 | 1 | 2 | 1 | ||||
| H. influenzae type b (n = 2) | 1 | NA | ||||||||||||
| S. pneumoniae (n = 7) | 1 | 2 | NA | 2 | 1 | |||||||||
| P. jirovecii (n = 5) | 1 | 3 | NA | 1 | 1 | |||||||||
| L. pneumophila (n = 1) | 1 | 1 | NA | |||||||||||
| K. pneumoniae (n = 37) | 1 | 1 | 7 | 2 | 1 | NA | 3 | 3 | 1 | |||||
| M. catarrhalis (n = 3) | 1 | NA | ||||||||||||
| H. influenzae (n = 7) | 2 | 1 | 3 | NA | ||||||||||
| A. baumannii (n = 4) | 3 | NA | ||||||||||||
| M. tuberculosis (n = 2) | 1 | 1 | NA | |||||||||||
a
Including 18 patients with double detections and 6 patients with triple detections by the FTD-33 assay or respiratory culture. HRV, human rhinovirus; IBV, influenza B virus; HCoV, human coronavirus; NA, not applicable.